1st Quarter - Report
TIBER CREEK GROUP for ASTRAZENECA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 469 Affordable and Safe Prescription Drug Importation Act, H.R. 1245 Affordable and Safe Prescription Drug Importation Act, issues related to pharmaceutical pricing and transparency. Issues regarding asthma/severe asthma/Family Asthma Act. Issues relating to 340b pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| SEAN RICHARDSON | — |
Medicare/Medicaid MMM
Issues relating to pharmaceutical pricing and transparency, HR 2550 Medicare Telehealth Parity Act of 2017. P.L. 115-123 - Bipartisan Budget Act of 2018, provisions relating to Part D coverage Gap.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| SEAN RICHARDSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.